<DOC>
	<DOCNO>NCT02344966</DOCNO>
	<brief_summary>The objective study evaluate prognostic factor acute leukemia patient invent molecular genetic test sensitive detection minimal residual disease , thereby study would contribute plan risk adapt treatment . Patients sample blood and/or bone marrow collect diagnosis process , treatment and/or thereafter</brief_summary>
	<brief_title>Cohort Study New Prognostic Factors With Peripheral Blood Bone Marrow Evaluation Time Diagnosis During Treatment Thereafter Acute Leukemia</brief_title>
	<detailed_description />
	<mesh_term>Leukemia</mesh_term>
	<mesh_term>Acute Disease</mesh_term>
	<criteria>Patients diagnose acute leukemia Severance Hospital . Both gender 16 Years old sign write informed consent document No comprehension willingness sign write informed consent document .</criteria>
	<gender>All</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2011</verification_date>
</DOC>